MSANet: Multi-Similarity and Attention Guidance for Boosting Few-Shot SegmentationEhtesham Iqbal, Sirojbek Safarov, Seongdeok Bang
Few-shot segmentation aims to segment unseen-class objects given only a handful of densely labeled samples. Prototype learning, where the support feature yields a singleor several prototypes by averaging global and local object information, has been widely used in FSS. However, utilizing only prototype vectors may be insufficient to represent the features for all training data. To extract abundant features and make more precise predictions, we propose a Multi-Similarity and Attention Network (MSANet) including two novel modules, a multi-similarity module and an attention module. The multi-similarity module exploits multiple feature-maps of support images and query images to estimate accurate semantic relationships. The attention module instructs the network to concentrate on class-relevant information. The network is tested on standard FSS datasets, PASCAL-5i 1-shot, PASCAL-5i 5-shot, COCO-20i 1-shot, and COCO-20i 5-shot. The MSANet with the backbone of ResNet-101 achieves the state-of-the-art performance for all 4-benchmark datasets with mean intersection over union (mIoU) of 69.13%, 73.99%, 51.09%, 56.80%, respectively. Code is available at https://github.com/AIVResearch/MSANet
1.6IRJan 27, 2020
The side effect profile of Clozapine in real world data of three large mental hospitalsEhtesham Iqbal, Risha Govind, Alvin Romero et al.
Objective: Mining the data contained within Electronic Health Records (EHRs) can potentially generate a greater understanding of medication effects in the real world, complementing what we know from Randomised control trials (RCTs). We Propose a text mining approach to detect adverse events and medication episodes from the clinical text to enhance our understanding of adverse effects related to Clozapine, the most effective antipsychotic drug for the management of treatment-resistant schizophrenia, but underutilised due to concerns over its side effects. Material and Methods: We used data from de-identified EHRs of three mental health trusts in the UK (>50 million documents, over 500,000 patients, 2835 of which were prescribed Clozapine). We explored the prevalence of 33 adverse effects by age, gender, ethnicity, smoking status and admission type three months before and after the patients started Clozapine treatment. We compared the prevalence of adverse effects with those reported in the Side Effects Resource (SIDER) where possible. Results: Sedation, fatigue, agitation, dizziness, hypersalivation, weight gain, tachycardia, headache, constipation and confusion were amongst the highest recorded Clozapine adverse effect in the three months following the start of treatment. Higher percentages of all adverse effects were found in the first month of Clozapine therapy. Using a significance level of (p< 0.05) out chi-square tests show a significant association between most of the ADRs in smoking status and hospital admissions and some in gender and age groups. Further, the data was combined from three trusts, and chi-square tests were applied to estimate the average effect of ADRs in each monthly interval. Conclusion: A better understanding of how the drug works in the real world can complement clinical trials and precision medicine.
0.3CLMar 10, 2019
Efficiently Reusing Natural Language Processing Models for Phenotype-Mention Identification in Free-text Electronic Medical Records: Methodology StudyHonghan Wu, Karen Hodgson, Sue Dyson et al.
Background: Many efforts have been put into the use of automated approaches, such as natural language processing (NLP), to mine or extract data from free-text medical records to construct comprehensive patient profiles for delivering better health-care. Reusing NLP models in new settings, however, remains cumbersome - requiring validation and/or retraining on new data iteratively to achieve convergent results. Objective: The aim of this work is to minimize the effort involved in reusing NLP models on free-text medical records. Methods: We formally define and analyse the model adaptation problem in phenotype-mention identification tasks. We identify "duplicate waste" and "imbalance waste", which collectively impede efficient model reuse. We propose a phenotype embedding based approach to minimize these sources of waste without the need for labelled data from new settings. Results: We conduct experiments on data from a large mental health registry to reuse NLP models in four phenotype-mention identification tasks. The proposed approach can choose the best model for a new task, identifying up to 76% (duplicate waste), i.e. phenotype mentions without the need for validation and model retraining, and with very good performance (93-97% accuracy). It can also provide guidance for validating and retraining the selected model for novel language patterns in new tasks, saving around 80% (imbalance waste), i.e. the effort required in "blind" model-adaptation approaches. Conclusions: Adapting pre-trained NLP models for new tasks can be more efficient and effective if the language pattern landscapes of old settings and new settings can be made explicit and comparable. Our experiments show that the phenotype-mention embedding approach is an effective way to model language patterns for phenotype-mention identification tasks and that its use can guide efficient NLP model reuse.